Urinary 17-Ketosteroids and Their Fractions in Women with Breast Cancer Treated by Endocrine Surgery
1960

Urinary 17-Ketosteroids in Women with Breast Cancer

Sample size: 22 publication Evidence: moderate

Author Information

Author(s): A. W. Sum, R. Hobkirk, Helen J. Stewart, D. W. Blair, A. P. M. Forrest

Primary Institution: University Department of Surgery, Western Infirmary, Glasgow

Hypothesis

The study investigates the levels of urinary 17-ketosteroids in women with advanced breast cancer treated by endocrine surgery.

Conclusion

The study found that adrenalectomy and oophorectomy significantly reduced urinary 17-ketosteroid levels, but the presence of these steroids post-surgery did not correlate with clinical response.

Supporting Evidence

  • Six of the twelve patients had objective evidence of regression of cancer following adrenalectomy.
  • Adrenalectomy and oophorectomy led to a significant decrease in urinary 17-ketosteroids.
  • Post-operative levels of 11-oxy 17-ketosteroids were present in patients receiving maintenance cortisone.

Takeaway

Doctors looked at urine samples from women with breast cancer to see how surgery affected certain hormones, and they found that surgery lowered these hormones, but it didn't always help the cancer get better.

Methodology

Urinary 17-ketosteroids were estimated in women with metastatic or recurrent mammary cancer treated by oophorectomy, adrenalectomy, or pituitary implantation, using chromatography and colorimetric methods.

Limitations

The study did not find a significant relationship between pre-operative steroid levels and clinical response to surgery.

Participant Demographics

The study involved post-menopausal women with advanced breast cancer.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication